By slowing gastric emptying, semaglutide may alter the timing and flow of bile, potentially leading to bile stasisa condition that can contribute to the formation of gallstones
Sharon Barr, executive vice president, biopharmaceuticals R&D at AstraZeneca, said, Building on the promising Phase I clinical data generated by Eccogene, we believe this oral GLP-1RA molecule could offer alternatives to current injectable therapies both as a potential monotherapy as well as in combination for cardiometabolic diseases such as type 2 diabetes, as well as for obesity
Key Ingredients Glutathione: A master antioxidant that targets the root causes of uneven skin tone around the eyes to promote a consistently clear, radiant, and healthy-looking appearance
Principal Investigator, Linus Pauling Institute Professor, Dept